Plasma miR-150-5p as a Biomarker for Chronic Obstructive Pulmonary Disease

References

• Vestbo J, Hurd SS, Agustí AG, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Am J Resp Crit Care. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP
   PubMed Web of Science ®Google Scholar
• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. Plos Med. 2006;3(11):e442. doi:10.1371/journal.pmed.0030442
   PubMed Web of Science ®Google Scholar
• Hu H, Nie Z, Lu Y, et al. Circulating miR-125b but not miR-125a correlates with acute exacerbations of chronic obstructive pulmonary disease and the expressions of inflammatory cytokines. Medicine. 2017;96(51):e9059. doi:10.1097/MD.0000000000009059
   PubMedGoogle Scholar
• Lareau SC, Fahy B, Meek P, Wang A. Chronic Obstructive Pulmonary Disease (COPD). Am J Resp Crit Care. 2019;199(1):P1–P2. doi:10.1164/rccm.1991P1
   PubMed Web of Science ®Google Scholar
• Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. doi:10.1016/S0140-6736(17)31222-9
   PubMed Web of Science ®Google Scholar
• Lin TL, Chen WW, Ding ZR, Wei SC, Huang ML, Li CH. Correlations between serum amyloid A, C‐reactive protein and clinical indices of patients with acutely exacerbated chronic obstructive pulmonary disease. J Clin Lab Anal. 2019;33(4):e22831. doi:10.1002/jcla.22831
   PubMed Web of Science ®Google Scholar
• Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J. 1999;14(5):1015–1022. doi:10.1183/09031936.99.14510159
   PubMed Web of Science ®Google Scholar
• Farrell O. Plasma Extracellular Vesicle miRNAs Can Identify Lung Cancer, Current Smoking Status, and Stable COPD. Int J Mol Sci. 2021;22(11):5803. doi:10.3390/ijms22115803
   PubMedGoogle Scholar
• Zhang J, Li S, Li L, et al. Exosome and Exosomal MicroRNA: trafficking, Sorting, and Function. Genomics Proteomics Bioinformatics. 2015;13(1):17–24. doi:10.1016/j.gpb.2015.02.001
   PubMed Web of Science ®Google Scholar
• Ezzie ME, Crawford M, Cho J, et al. Gene expression networks in COPD: microRNA and mRNA regulation. Thorax. 2012;67(2):122–131. doi:10.1136/thoraxjnl-2011-200089
   PubMed Web of Science ®Google Scholar
• Wang J, Chen J, Sen S. MicroRNA as Biomarkers and Diagnostics. J Cell Physiol. 2016;231(1):25–30. doi:10.1002/jcp.25056
   PubMed Web of Science ®Google Scholar
• O’Leary L, Sevinc K, Papazoglou IM, et al. Airway smooth muscle inflammation is regulated by microRNA-145 in COPD. FEBS Lett. 2016;590(9):1324–1334. doi:10.1002/1873-3468.12168
   PubMedGoogle Scholar
• Bartel DP. MicroRNAs: genomics, Biogenesis, Mechanism, and Function. Cell. 2004;116(2):281–297. doi:10.1016/S0092-8674(04)00045-5
   PubMed Web of Science ®Google Scholar
• Yao MY, Zhang WH, Ma WT, Liu QH, Xing LH, Zhao GF. Long non-coding RNA MALAT1 exacerbates acute respiratory distress syndrome by upregulating ICAM-1 expression via microRNA-150-5p downregulation. Aging. 2020;12(8):6570–6585. doi:10.18632/aging.102953
   PubMedGoogle Scholar
• Chen X, Zeng K, Xu M, et al. SP1-induced lncRNA-ZFAS1 contributes to colorectal cancer progression via the miR-150-5p/VEGFA axis. Cell Death Dis. 2018;9(10). doi:10.1038/s41419-018-0962-6
   Google Scholar
• Kakan SS, Edman MC, Yao A, et al. Tear miRNAs Identified in a Murine Model of Sjögren’s Syndrome as Potential Diagnostic Biomarkers and Indicators of Disease Mechanism. Front Immunol. 2022;13. doi:10.3389/fimmu.2022.833254
   PubMedGoogle Scholar
• Chen J, Papp G, Póliska S, et al. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren’s syndrome. PLoS One. 2017;12(3):e0174585. doi:10.1371/journal.pone.0174585
   PubMed Web of Science ®Google Scholar
• Hosokawa K, Kajigaya S, Feng X, et al. A plasma microRNA signature as a biomarker for acquired aplastic anemia. Haematologica. 2017;102(1):69–78. doi:10.3324/haematol.2016.151076
   PubMed Web of Science ®Google Scholar
• Scrutinio D, Conserva F, Passantino A, Iacoviello M, Lagioia R, Gesualdo L. Circulating microRNA-150-5p as a novel biomarker for advanced heart failure: a genome-wide prospective study. J Heart Lung Transplant. 2017;36(6):616–624. doi:10.1016/j.healun.2017.02.008
   PubMed Web of Science ®Google Scholar
• Zhu M, Ye L, Zhu G, et al. ROS-Responsive miR-150-5p Downregulation Contributes to Cigarette Smoke-Induced COPD via Targeting IRE1α. Oxid Med Cell Longev. 2022;2022:1–23. doi:10.1155/2022/5695005
   Google Scholar
• Halpin DMG, Criner GJ, Papi A, et al. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Resp Crit Care. 2021;203(1):24–36. doi:10.1164/rccm.202009-3533SO
   PubMed Web of Science ®Google Scholar
• Savarimuthu FS, Davidson MR, Tan ME, et al. MicroRNA-34c is associated with emphysema severity and modulates SERPINE1 expression. Bmc Genomics. 2014;15:88. doi:10.1186/1471-2164-15-88
   PubMedGoogle Scholar
• Celli BR, Locantore N, Yates J, et al. Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease. Am J Resp Crit Care. 2012;185(10):1065–1072. doi:10.1164/rccm.201110-1792OC
   PubMed Web of Science ®Google Scholar
• Pattarayan D, Thimmulappa RK, Ravikumar V, Rajasekaran S. Diagnostic Potential of Extracellular MicroRNA in Respiratory Diseases. Clin Rev Allerg Immu. 2018;54(3):480–492. doi:10.1007/s12016-016-8589-9
   PubMed Web of Science ®Google Scholar
• Soeda S, Ohyashiki JH, Ohtsuki K, Umezu T, Setoguchi Y, Ohyashiki K. Clinical relevance of plasma miR-106b levels in patients with chronic obstructive pulmonary disease. Int J Mol Med. 2013;31(3):533–539. doi:10.3892/ijmm.2013.1251
   PubMed Web of Science ®Google Scholar
• Mizuno S, Bogaard HJ, Gomez-Arroyo J, et al. MicroRNA-199a-5p Is Associated With Hypoxia-Inducible Factor-1α Expression in Lungs From Patients With COPD. Chest. 2012;142(3):663–672. doi:10.1378/chest.11-2746
   PubMed Web of Science ®Google Scholar
• Hassan T, Carroll TP, Buckley PG, et al. miR-199a-5p Silencing Regulates the Unfolded Protein Response in Chronic Obstructive Pulmonary Disease and α1-Antitrypsin Deficiency. Am J Resp Crit Care. 2014;189(3):263–273. doi:10.1164/rccm.201306-1151OC
   PubMed Web of Science ®Google Scholar
• Christenson SA, Brandsma CA, Campbell JD, et al. miR-638 regulates gene expression networks associated with emphysematous lung destruction. Genome Med. 2013;5(12):114. doi:10.1186/gm519
   PubMed Web of Science ®Google Scholar
• Sato T, Liu X, Nelson A, et al. Reduced miR-146a Increases Prostaglandin E2 in Chronic Obstructive Pulmonary Disease Fibroblasts. Am J Resp Crit Care. 2010;182(8):1020–1029. doi:10.1164/rccm.201001-0055OC
   PubMed Web of Science ®Google Scholar
• Punga T, Panse R, Andersson M, Truffault F, Berrih Aknin S, Punga AR. Circulating miRNAs in myasthenia gravis: miR‐150‐5p as a new potential biomarker. Ann Clin Transl Neur. 2014;1(1):49–58. doi:10.1002/acn3.24
   PubMedGoogle Scholar
• Scherrer N, Fays F, Mueller B, et al. MicroRNA 150-5p Improves Risk Classification for Mortality within 90 Days after Acute Ischemic Stroke. J Stroke. 2017;19(3):323–332. doi:10.5853/jos.2017.00423
   PubMed Web of Science ®Google Scholar
• Perez-Sanchez C, Font-Ugalde P, Ruiz-Limon P, et al. Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients. Hum Mol Genet. 2018;27(5):875–890. doi:10.1093/hmg/ddy008
   PubMedGoogle Scholar
• Casabonne D, Benavente Y, Seifert J, et al. Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR - 223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study. Int J Cancer. 2020;147(5):1315–1324. doi:10.1002/ijc.32894
   PubMedGoogle Scholar
• Lu W, Zhang H, Niu Y, et al. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Mol Cancer. 2017;16(1). doi:10.1186/s12943-017-0685-9
   Google Scholar
• Yan L, Jiao D, Hu H, et al. Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach. Exp Biol Med. 2017;242(7):709–717. doi:10.1177/1535370216677353
   Google Scholar
• Zhang Y, Wang F, Chen G, He R, Yang L. LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p/AKT3 axis. Cell Biosci. 2019;9:54. doi:10.1186/s13578-019-0302-2
   PubMed Web of Science ®Google Scholar
• Ou M, Zhao H, Ji G, Zhao X, Zhang Q. Long noncoding RNA MALAT1 contributes to pregnancy-induced hypertension development by enhancing oxidative stress and inflammation through the regulation of the miR-150-5p/ET-1 axis. FASEB J. 2020;34(5):6070–6085. doi:10.1096/fj.201902280R
   PubMed Web of Science ®Google Scholar
• Yang Y, Tai W, Lu N, et al. lncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis. Aging. 2020;12(10):9085–9102. doi:10.18632/aging.103176
   PubMedGoogle Scholar
• Chang W, Tsai M, Hung J, et al. miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells. Cancers. 2021;13(24):6252. doi:10.3390/cancers13246252
   PubMedGoogle Scholar
• Keller A, Ludwig N, Fehlmann T, et al. Low miR-150-5p and miR-320b Expression Predicts Reduced Survival of COPD Patients. Cells-Basel. 2019;8(10):1162. doi:10.3390/cells8101162
   PubMedGoogle Scholar
• Vimalraj S, Subramanian R, Dhanasekaran A. LncRNA MALAT1 Promotes Tumor Angiogenesis by Regulating MicroRNA-150-5p/VEGFA Signaling in Osteosarcoma: in-Vitro and In-Vivo Analyses. Front Oncol. 2021;11:742789. doi:10.3389/fonc.2021.742789
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhu M, Wang H, Liu H. Suppression of lncRNA MALAT1 reduces pro-inflammatory cytokines production by regulating miR-150-5p/ZBTB4 axis through JAK/STAT signal pathway in systemic juvenile idiopathic arthritis. Cytokine. 2021;138:155397. doi:10.1016/j.cyto.2020.155397
   PubMedGoogle Scholar
• Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. Lancet. 2022;399(10342):2227–2242. doi:10.1016/S0140-6736(22)00470-6
   PubMed Web of Science ®Google Scholar
• Pottelberge GRV, Mestdagh P, Bracke KR, et al. MicroRNA Expression in Induced Sputum of Smokers and Patients with Chronic Obstructive Pulmonary Disease. Am J Resp Crit Care. 2011;183(7):898–906. doi:10.1164/rccm.201002-0304OC
   PubMedGoogle Scholar